# Procaps Group S.A. (PROC)

**Exchange:** NASDAQ  
**Sector:** Healthcare  
**Price:** $0.03 (+3.52%)

> Procaps Group S.A. is a leading pharmaceutical company specializing in the development, manufacturing, and commercialization of pharmaceutical and nutritional products. The company is recognized for its innovation in the softgel and related technologies, which are critical for creating advanced dosage forms and drug delivery systems. With an emphasis on improving health outcomes, Procaps Group serves a diverse range of sectors, including prescription medications, over-the-counter products, and a variety of nutritional supplements.

One of the key features of Procaps Group is its commitment to research and development, which has positioned it as a pioneer in the Latin American pharmaceutical industry. Operating with a global footprint, the company supplies its products to more than 50 countries worldwide, impacting industries such as healthcare, wellness, and nutrition.

Procaps Group S.A. holds a significant place in the pharmaceutical market due to its focus on technological advancements and its ability to meet global health demands through strategic partnerships and supply chain efficiencies. Its role is particularly vital in supporting disease prevention and management through its wide array of innovative health solutions.

Financial data not yet available for this company.

Source: [CompaniesByCap](https://companiesbycap.com/company/PROC)